PolicyBrief
H.R. 8053
119th CongressMar 24th 2026
DPA Emerging Technology Act of 2026
IN COMMITTEE

The DPA Emerging Technology Act of 2026 modernizes the Defense Production Act Committee by establishing a permanent subcommittee to analyze emerging technologies and evaluate the feasibility of a strategic biomanufacturing reserve.

Stephen Lynch
D

Stephen Lynch

Representative

MA-8

LEGISLATION

New Emerging Tech Act Mandates AI and Quantum Strategy: Federal Defense Committee Gets a Digital-Age Upgrade

The DPA Emerging Technology Act of 2026 is essentially a software update for the government’s 1950s-era playbook on national defense production. It forces the Defense Production Act Committee—the group responsible for making sure the U.S. has the industrial muscle to handle emergencies—to modernize its structure. Under Section 2, the Committee must now meet at least twice a year and is officially authorized to spin up new subcommittees to handle specialized coordination between federal agencies. It’s a move toward more active management rather than just reacting when a crisis hits, ensuring that the people at the top are actually in the same room talking about supply chains before they break.

The New Tech Watchdogs

The centerpiece of this bill is the creation of a permanent Subcommittee on Emerging Technology. This group is tasked with figuring out how things like artificial intelligence, robotics, quantum computing, and semiconductors affect our national security. If you work in tech or manufacturing, this matters because this subcommittee will define what counts as "covered technology" (Section 2). This definition could eventually influence which industries get federal support or which supply chains get extra scrutiny. Think of it as the government finally acknowledging that a 21st-century defense isn't just about steel and oil, but also about the code and chips that run our daily lives.

Preparing for the Next Bio-Crisis

Taking a lesson from recent global supply chain meltdowns, Section 3 of the bill requires a deep dive into our biological manufacturing capabilities. Within 18 months, the new subcommittee must hand over a report evaluating a "strategic reserve of critical biomanufacturing inputs." For someone working in a lab or a pharmacy, this could eventually mean a more stable supply of the raw materials needed for medicines and vaccines. The bill wants to know exactly what resources we need to keep in stock so we aren't caught off guard if a global trade route shuts down or a new health emergency spikes demand for specific biological components.

Cleaning Up the Fine Print

While most of the bill focuses on high-tech strategy, Section 4 handles some basic housekeeping by fixing a typo in the original 1950 Act’s title. It’s a small detail, but it ensures the legal citations are airtight. The broader challenge here lies in the "Medium" vagueness of how these new subcommittees will operate. Because the bill gives the subcommittee the power to define its own scope regarding "covered technology," there’s a lot of room for interpretation. Whether you’re a software engineer or a warehouse manager, the real-world impact will depend on how broadly this group defines the tech that is "essential" to the country’s defense.